NCT01874327View on ClinicalTrials.gov

Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2018

Study Completion Date

September 30, 2018

Conditions
Children at Risk for ASD
Interventions
BEHAVIORAL

Baby JASPER

Intervention focuses on core deficits of joint attention, play, engagement, and regulation embedded within AEPS curriculum

BEHAVIORAL

Standard Baby Classroom

Assessment, Education and Programming System (AEPS) for Infants and Children curriculum focused on early developmental milestones in fine and gross motor, cognitive, adaptive and social areas

Trial Locations (1)

90024

UCLA Semel Institue, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT01874327 - Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD) | Biotech Hunter | Biotech Hunter